Diana Burgueno-Vega, MD

Original Research

Treatment of Stage 4 Pressure Injuries With Autologous Heterogenous Skin Construct: A Single-Center Retrospective Study

05/03/2023

This single-center retrospective cohort study sought to determine the effectiveness of autologous heterogenous skin construct in the treatment of recalcitrant stage 4 pressure injuries.

This single-center...

05/03/2023

ePlasty

Case Report

Use of an Autologous Heterogenous Skin Construct in the Treatment of Intractable Late-Effect Radiation Wounds: Case Series

06/14/2023

Melodie Blakely , DPT, CWS, MS;

Walter A. Conlan III, MD, CWS, UHM, CWSP;

Diana Burgueno-Vega , MD;

Dilip Shahani , DMSc, PA-C;

This case series describes the use of an autologous heterogenous skin construct made from a small full-thickness sample of the patient’s healthy skin.

This case series describes the...

06/14/2023

ePlasty

Closure of Stage IV Pressure Injuries with an Autologous Heterogeneous Skin Construct

Objective: Pressure injuries (PIs) are a difficult, costly and growing problem in the US and worldwide. Available treatments have high failure rates and, even when they are successful, wo...

Deana S. Shenaq , MD;

Mark S. Granick , MD;

Diana Burgueno-Vega , MD;

Nikolai Sopko , MD, PhD;

Melodie Blakely , DPT, CWS, MS;

Diane Duncan , MD;

Edward W. Swanson , MD;

08/19/2021

Use of an Autologous Heterogenous Skin Construct in the Treatment of Intractable Late-effect Radiation Wounds

Introduction: Late-effect radiation induced wounds represent a particularly difficult category of wounds to manage and treat. Fibrosis, impaired cellular activity, ischemia and wound chro...

Walter A. Conlan III, MD, CWS, UHM, CWSP;

Diana Burgueno-Vega , MD;

Dilip Shahani , DMSc, PA-C;

Melodie Blakely , DPT, CWS, MS;

08/19/2021